Advertisement
Advertisement
U.S. Markets open in 40 mins
Advertisement
Advertisement
Advertisement
Advertisement

Kintara Therapeutics, Inc. (KTRA)

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Add to watchlist
0.7799-0.0384 (-4.69%)
At close: 04:00PM EST
Advertisement
Get access to 40+ years of historical data with Yahoo Finance Plus Essential.Learn more
Currency in USD

Valuation Measures

Yahoo Finance Plus required to access annual data
Annual
Quarterly
Yahoo Finance Plus required to access monthly data
Monthly
Subscribe to Yahoo Finance Plus Essential to download historical data
 
As of Date: 11/30/2021
Current
Market Cap (intraday) 5
N/A
Enterprise Value 3
N/A
Trailing P/E
N/A
Forward P/E 1
N/A
PEG Ratio (5 yr expected) 1
N/A
Price/Sales (ttm)
N/A
Price/Book (mrq)
N/A
Enterprise Value/Revenue 3
N/A
Enterprise Value/EBITDA 7
N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 1.54
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 33.3500
52 Week Low 30.7050
50-Day Moving Average 30.8916
200-Day Moving Average 31.5008

Share Statistics

Avg Vol (3 month) 32.12M
Avg Vol (10 day) 3915.82k
Shares Outstanding 532.62M
Implied Shares Outstanding 6N/A
Float 828.97M
% Held by Insiders 11.04%
% Held by Institutions 18.39%
Shares Short (Jul 29, 2021) 41.28M
Short Ratio (Jul 29, 2021) 40.89
Short % of Float (Jul 29, 2021) 44.00%
Short % of Shares Outstanding (Jul 29, 2021) 43.93%
Shares Short (prior month Jun 29, 2021) 41.32M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3May 07, 2019
Ex-Dividend Date 4N/A
Last Split Factor 21:10
Last Split Date 3May 07, 2019

Financial Highlights

Fiscal Year

Fiscal Year Ends Jun 29, 2020
Most Recent Quarter (mrq)Mar 30, 2021

Profitability

Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-92.06%
Return on Equity (ttm)-356.77%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)N/A
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)N/A
EBITDA N/A
Net Income Avi to Common (ttm)-38.59M
Diluted EPS (ttm)N/A
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)16.22M
Total Cash Per Share (mrq)0.5
Total Debt (mrq)503k
Total Debt/Equity (mrq)3.12
Current Ratio (mrq)6.07
Book Value Per Share (mrq)N/A

Cash Flow Statement

Operating Cash Flow (ttm)-16.75M
Levered Free Cash Flow (ttm)-5.46M
Advertisement
Advertisement